In disease model mice of Crohn’s disease [2], ulcerative colitis [3,4], and contact hypersensitivity [5,6], we found that IL-19 gene-deficient (KO) mice showed an exacerbation of symptoms, and IL-19 acted as an inhibitor of colon and cutaneous inflammation. This evidence concerns the gene IL19 and Crohn disease.